Aykut Kankoç

Dr. Aykut Kankoç

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2024 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
MSMuhammet Sayan
Muhammet Sayan
AKAykut Kankoç
Aykut Kankoç
MAMuhammet Tarik Aslan
Muhammet Tarik Aslan
IAIrmak Akarsu
Irmak Akarsu
IKİsMail Cuneyt Kurul
İsMail Cuneyt Kurul
ACAli Celik
Ali Celik
Muhammet Sayan, M.D., Aykut Kankoc, M.D., Muhammet Tarik Aslan, M.D., Irmak Akarsu, M.D., İsmail Cuneyt Kurul, M.D., Ali Celik, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.24.052

5 October 2021 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
MSMuhammet Sayan
Muhammet Sayan
M.M.D.
M.D.
AKAykut Kankoç
Aykut Kankoç
DODilvin Ozkan
Dilvin Ozkan
ACAli Celik
Ali Celik
ATAbdullah Irfan Tastepe
Abdullah Irfan Tastepe
Muhammet Sayan, M.D., Aykut Kankoc, M.D., Dilvin Ozkan, M.D., Ali Celik, M.D., Ismail Cuneyt Kurul, M.D., Abdullah Irfan Tastepe, M.D.. Korean J Thorac Cardiovasc Surg -0001;0:. https://doi.org/10.5090/jcs.21.032

13 December 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
MTMerve Şatır Türk
Merve Şatır Türk
IAIrmak Akarsu
Irmak Akarsu
ITİsmail Tombul
İsmail Tombul
AKAykut Kankoç
Aykut Kankoç
NÖNur Dilvin Özkan
Nur Dilvin Özkan
ATAbdullah İrfan Taştepe
Abdullah İrfan Taştepe
Background/aim: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia. Materials and methods: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator. Results: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04). Conclusion: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.

1 February 2021 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MSMuhammet Sayan
Muhammet Sayan
AKAykut Kankoç
Aykut Kankoç
NONur Dilvin Ozkan
Nur Dilvin Ozkan
ABAynur Bas
Aynur Bas
ACAli Celik
Ali Celik
ATAbdullah Irfan Tastepe
Abdullah Irfan Tastepe

24 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
SIStephanie Iser
Stephanie Iser
SHSarah Hintermair
Sarah Hintermair
AVAlexander Varga
Alexander Varga
AÇAli Çelik
Ali Çelik
MSMuhammet Sayan
Muhammet Sayan
Bahil GhanimBahil Ghanim
Bahil Ghanim
Evoked from asbestos-induced inflammation, pleural mesothelioma represents a fatal diagnosis. Therapy ranges from nihilism to aggressive multimodality regimens. However, it is still unclear who ultimately benefits from which treatment. We aimed to re-challenge inflammatory-related biomarkers’ prognostic value in times of modern immune-oncology and lung-sparing surgery. The biomarkers (leukocytes, hemoglobin, platelets, neutrophils, lymphocytes, monocytes, neutrophil–lymphocyte ratio (NLR), lymphocyte–monocyte ratio (LMR), platelet–lymphocyte ratio (PLR), C-reactive protein (CRP)) and clinical characteristics (age, sex, histology, therapy) of 98 PM patients were correlated to overall survival (OS). The median OS was 19.4 months. Significant OS advantages (Log-Rank) were observed in multimodal treatment vs. others (26.1 vs. 7.2 months, p < 0.001), surgery (pleurectomy/decortication) vs. no surgery (25.5 vs. 3.8 months, p < 0.001), a high hemoglobin level (cut-off 12 g/dL, 15 vs. 24.2 months, p = 0.021), a low platelet count (cut-off 280 G/L, 26.1 vs. 11.7 months, p < 0.001), and a low PLR (cut-off 194.5, 25.5 vs. 12.3 months, p = 0.023). Histology (epithelioid vs. non-epithelioid, p = 0.002), surgery (p = 0.004), CRP (cut-off 1 mg/dL, p = 0.039), and platelets (p = 0.025) were identified as independent prognostic variables for this cohort in multivariate analysis (Cox regression, covariates: age, sex, histology, stage, CRP, platelets). Our data verified the previously shown prognostic role of systemic inflammatory parameters in patients treated with lung-sparing surgery within multimodality therapy.

29 June 2023 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
MSMuhammet Sayan
Muhammet Sayan
ACAli Celik
Ali Celik
AKAykut Kankoç
Aykut Kankoç
IAIrmak Akarsu
Irmak Akarsu
MAMuhammet Tarik Aslan
Muhammet Tarik Aslan
ATAbdullah Irfan Tastepe
Abdullah Irfan Tastepe